The Chênevert Family gift will keep children close to home for lifesaving bone marrow transplants, stem cell transplants and gene therapy.
Connecticut Children’s has received a $3.5 million gift from long-time donors Debra and Louis Chênevert and their daughters, Sophie Chênevert-Schilke and Lisa Chênevert-Krause, to support cutting-edge cellular and gene therapy treatment and research in the hospital’s new eight-story clinical tower, set to open in December 2025. In recognition of this transformative gift, the new cellular and gene therapy unit in the tower will be named the Chênevert Family Advanced Cellular and Gene Therapy Unit.
“Bone marrow transplants, stem cell transplants and gene therapy are critical, lifesaving procedures for pediatric cancers and other diseases,” said Dr. Jim Shmerling, President and CEO, Connecticut Children’s. “Thanks to the amazing generosity of the Chênevert Family, our patients will no longer need to go out of state for these cutting-edge treatments. We are immensely grateful for their support.”